.png)
Breast Cancer Research: Change Starts With You
Living with ER+ HER2- advanced breast cancer? If your cancer returned during or shortly after hormone therapy, a research study may be an option for you.
ER+ HER2- is a type of breast cancer that uses a hormone called estrogen to grow. Additionally, the HER2 protein can act like a supercharger for cancer, making it grow and spread faster. Since ER+ HER2- breast cancer doesn't have HER2 proteins (which is why you see a negative sign at the end of the name), it might not be as aggressive. Knowing this helps doctors choose the right treatment for you.
Don’t know your breast cancer type? While we are looking for individuals with this specific type of advanced breast cancer, many factors can affect your eligibility. The study team will screen you for your breast cancer type, so don't let it stop you from learning more.
While HER2+ breast cancers can be treated with drugs targeting this protein, ER+ HER2- breast cancers are typically managed with hormone therapies that either help to lower the amount of estrogen in your body or block them from working.
This study is designed to test an oral medication (taken by mouth) for advanced breast cancer. The study will compare this new medication to an existing treatment.*
You may be able to join this study if:
If this sounds like you, and you’re interested in participating, complete this quick form today!
*Both study drugs will be combined with another type of cancer medicine.
People of color are underrepresented in clinical research. This is a problem because it means we don't fully understand how new and existing treatments work for different people.
By participating in research, you can help make sure that future treatments are safe and effective for everyone. Your perspective matters!
The NOWINCLUDED cancer community is here to support you in making better-informed health decisions. If you’re not already a member, join today! It’s free.
As a member you gain:
Together, we can make healthcare more inclusive and ensure that everyone has the opportunity for better health. Data from this study will be used to develop safe and effective treatments for advanced breast cancer.
